X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Strides Arcolab with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs ADCOCK INGRAM (S. Africa) - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STRIDES SHASUN LTD   ADCOCK INGRAM
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
ADCOCK INGRAM
Jun-14
STRIDES SHASUN LTD/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,275403-   
Low Rs918291-   
Sales per share (Unadj.) Rs389.6119.9-  
Earnings per share (Unadj.) Rs28.0-30.2-  
Cash flow per share (Unadj.) Rs48.9-25.0-  
Dividends per share (Unadj.) Rs4.500-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs303.194.1-  
Shares outstanding (eoy) m89.42168.78-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.82.9 97.3%   
Avg P/E ratio x39.2-11.5 -341.4%  
P/CF ratio (eoy) x22.4-13.9 -161.8%  
Price / Book Value ratio x3.63.7 98.1%  
Dividend payout %16.10-   
Avg Mkt Cap Rs m98,03658,557 167.4%   
No. of employees `0005.84.3 135.1%   
Total wages/salary Rs m5,8813,675 160.0%   
Avg. sales/employee Rs Th6,005.94,714.3 127.4%   
Avg. wages/employee Rs Th1,014.0856.1 118.4%   
Avg. net profit/employee Rs Th431.2-1,187.9 -36.3%   
INCOME DATA
Net Sales Rs m34,83420,238 172.1%  
Other income Rs m1,686142 1,189.5%   
Total revenues Rs m36,52020,380 179.2%   
Gross profit Rs m6,428-3,507 -183.3%  
Depreciation Rs m1,872873 214.3%   
Interest Rs m2,269548 413.9%   
Profit before tax Rs m3,973-4,787 -83.0%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m470299 157.1%   
Profit after tax Rs m2,501-5,100 -49.0%  
Gross profit margin %18.5-17.3 -106.5%  
Effective tax rate %11.8-6.2 -189.3%   
Net profit margin %7.2-25.2 -28.5%  
BALANCE SHEET DATA
Current assets Rs m38,16514,823 257.5%   
Current liabilities Rs m30,4028,340 364.5%   
Net working cap to sales %22.332.0 69.6%  
Current ratio x1.31.8 70.6%  
Inventory Days Days77111 69.7%  
Debtors Days Days104124 84.3%  
Net fixed assets Rs m37,6398,640 435.6%   
Share capital Rs m89494 951.6%   
"Free" reserves Rs m26,2100-   
Net worth Rs m27,10515,885 170.6%   
Long term debt Rs m16,3775,582 293.4%   
Total assets Rs m81,16830,008 270.5%  
Interest coverage x2.8-7.7 -35.6%   
Debt to equity ratio x0.60.4 171.9%  
Sales to assets ratio x0.40.7 63.6%   
Return on assets %5.9-15.2 -38.7%  
Return on equity %9.2-32.1 -28.7%  
Return on capital %12.1-19.8 -60.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m9,3890-   
CASH FLOW
From Operations Rs m2,8811,727 166.8%  
From Investments Rs m-7,051-530 1,329.4%  
From Financial Activity Rs m3,3825,066 66.8%  
Net Cashflow Rs m-7886,263 -12.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.56 Rs / ZAR

Compare STRIDES SHASUN LTD With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare STRIDES SHASUN LTD With: UNICHEM LAB  PFIZER  ABBOTT INDIA  STERLING BIOTECH  AJANTA PHARMA  



Today's Market

Firm US Markets; Sun Pharma, Software Stocks & Other Top Cues to Sway the Markets Today(Pre-Open)

Indian share markets finished the previous trading session on a strong note amid firm Asian markets after comments from a Federal Reserve official eased worries about faster rate hikes in US.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

The Blueprint for Sensex 100,000(The 5 Minute Wrapup)

Feb 20, 2018

Investing in stocks is not about index gazing. There are 3-Ms that could help pick the right stocks.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

A New Quest for the Stock Market's MOST Profitable Ideas...(Smart Contrarian)

Feb 23, 2018

If you want to receive the best ideas in the Indian stick markets...you need to heed this important announcement.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Feb 23, 2018 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD - AJANTA PHARMA COMPARISON

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS